- Molecular NameBetahistine
- SynonymNA
- Weight136.198
- Drugbank_IDN/A
- ACS_NO5638-76-6
- Show 3D model
- LogP (experiment)0.68
- LogP (predicted, AB/LogP v2.0)0.62
- pkaN/A
- LogD (pH=7, predicted)-2.01
- Solubility (experiment)N/A
- LogS (predicted, ACD/Labs)(ph=7)0.87
- LogSw (predicted, AB/LogsW2.0)497.75
- Sw (mg/ml) (predicted, ACD/Labs)134.66
- No.of HBond Donors1
- No.of HBond Acceptors2
- No.of Rotatable Bonds3
- TPSA24.92
- StatusN/A
- AdministrationN/A
- PharmacologyAn antivertigo drug. It is commonly prescribed to patients with balance disorders or to alleviate vertigo symptoms associated with Ménière's disease.
- Absorption_value100.0
- Absorption (description)N/A
- Caco_2N/A
- BioavailabilityN/A
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmTo 2-(2-aminoethyl)pyridine and 2-pyridylacetic acid
- Half life3~4 h
- ExcretionN/A
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityN/A
- LD50 (rat)N/A
- LD50 (mouse)N/A